NewsBioMarin Pharmaceutical to Acquire Inozyme Pharma for ~$270M, Strengthening its Enzyme Therapies PortfolioByRidhi RastogiMay 19, 20250Comments
NewsGSK Receives the MHLW’s Approval for Blenrep (Belantamab Mafodotin) Regimens to Treat R/R Multiple MyelomaByRidhi RastogiMay 19, 20250Comments
NewsBMS’ Opdivo Receives the EC’s Approval as a Perioperative Treatment of Resectable NSCLCByRidhi RastogiMay 19, 20250Comments
Weekly SnapshotPharmaShots Weekly Snapshots (May 12, 2025 – May 16, 2025) ByRidhi RastogiMay 16, 20250Comments
NewsBioCryst Reports the US FDA’s NDA Acceptance and Priority Review of Orladeyo for Hereditary Angioedema (HAE)ByRidhi RastogiMay 16, 20250Comments
NewsTravere Therapeutics Reports the US FDA’s sNDA Acceptance of Filspari for Focal Segmental Glomerulosclerosis (FSGS)ByRidhi RastogiMay 16, 20250Comments
NewsThe US FDA Approves Incyte’s Zynyz to Treat Adults with Squamous Cell Anal Carcinoma (SCAC)ByRidhi RastogiMay 16, 20250Comments
NewsRznomics Partners with Eli Lilly for RNA Editing TherapeuticsByDipanshu DixitMay 16, 20250Comments
